George P C Salmond
Overview
Explore the profile of George P C Salmond including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
3868
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sandoval C, Salmond G
Front Microbiol
. 2025 Jan;
15:1500889.
PMID: 39881986
The opportunistic pathogen sp. ATCC 39006 (S39006) is a rod-shaped, motile, Gram-negative bacterium that produces a ????-lactam antibiotic (a carbapenem) and a bioactive red-pigmented tripyrrole antibiotic, prodigiosin. It is also...
2.
Murphy A, Corney M, Monson R, Matilla M, Salmond G, Leeper F
ACS Chem Biol
. 2023 Apr;
18(5):1148-1157.
PMID: 37068480
, a plant-pathogenic bacterium, produces solanimycin, a potent hybrid polyketide/nonribosomal peptide (PKS/NRPS) anti-fungal compound. The biosynthetic gene cluster responsible for synthesis of this compound has been identified. Because of instability,...
3.
Matilla M, Monson R, Salmond G
Trends Microbiol
. 2023 Mar;
31(10):1085-1086.
PMID: 36958995
No abstract available.
4.
Matilla M, Evans T, Martin J, Udaondo Z, Lomas-Martinez C, Rico-Jimenez M, et al.
Microb Biotechnol
. 2022 Dec;
16(8):1690-1700.
PMID: 36528875
Global population growth makes it necessary to increase agricultural production yields. However, climate change impacts and diseases caused by plant pathogens are challenging modern agriculture. Therefore, it is necessary to...
5.
Magaziner S, Salmond G
Front Microbiol
. 2022 Nov;
13:1010330.
PMID: 36386655
Widespread multidrug antimicrobial resistance in emerging pathogens has led to a renewed interest in phage therapy as an alternative or supplement to traditional small molecule drugs. The primary limiting factors...
6.
Zurcher J, Robertson W, Kappes T, Petris G, Elliott T, Salmond G, et al.
Science
. 2022 Oct;
378(6619):516-523.
PMID: 36264827
The near-universal genetic code defines the correspondence between codons in genes and amino acids in proteins. We refactored the structure of the genetic code in and created orthogonal genetic codes...
7.
Matilla M, Monson R, Murphy A, Schicketanz M, Rawlinson A, Duncan C, et al.
mBio
. 2022 Oct;
13(6):e0247222.
PMID: 36214559
The increasing emergence of drug-resistant fungal infections has necessitated a search for new compounds capable of combating fungal pathogens of plants, animals, and humans. Microorganisms represent the main source of...
8.
Couturier M, Bhalara H, Monson R, Salmond G, Leeper F
RSC Chem Biol
. 2021 Aug;
2(2):551-555.
PMID: 34458798
A biosynthetic pathway for the red-antibiotic, prodigiosin, was proposed over a decade ago but not all the suggested intermediates could be detected experimentally. Here we show that a thioester that...
9.
Robertson W, Funke L, de la Torre D, Fredens J, Elliott T, Spinck M, et al.
Science
. 2021 Jun;
372(6546):1057-1062.
PMID: 34083482
It is widely hypothesized that removing cellular transfer RNAs (tRNAs)-making their cognate codons unreadable-might create a genetic firewall to viral infection and enable sense codon reassignment. However, it has been...
10.
Dorman M, Domman D, Poklepovich T, Tolley C, Zolezzi G, Kane L, et al.
Nat Commun
. 2020 Oct;
11(1):4918.
PMID: 33004800
In order to control and eradicate epidemic cholera, we need to understand how epidemics begin, how they spread, and how they decline and eventually end. This requires extensive sampling of...